International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT).
暂无分享,去创建一个
Keith McNeil | Robyn J. Barst | Stuart Rich | Paul A. Corris | Thomas M. Egan | Sergio Harari | M. Schluchter | G. Patterson | P. Corris | C. Keller | E. Trulock | M. Zamora | S. Rich | R. Barst | S. Harari | R. Keenan | V. Tapson | T. Egan | M. Hertz | L. Rubin | L. Ginns | R. Aris | E. Garrity | Marshall I. Hertz | Mark D. Schluchter | G. Mallory | R. Barbers | M. Baz | T. Kirby | J. Dark | Robert M. Aris | Richard G. Barbers | Maher A. Baz | Willem I. de Boer | John H. Dark | R. Duane Davis | Jim J. Eagan | Edward R. Garrity | Leo C. Ginns | Sheila G. Haworth | Robert J. Keenan | Cesar A. Keller | Steven Kesten | Thomas Kirby | Timothy J. Locke | George B. Mallory | Paradis Il | G. A. Patterson | Lewis J. Rubin | Larry L. Schulman | Gerard Simmoneau | Victor F. Tapson | Elbert P. Trulock | Carol E. Vreim | Martin R. Zamora | K. Mcneil | R. Davis | L. Schulman | S. Haworth | S. Kesten | C. Vreim | G. Simmoneau | W. D. Boer | T. Locke | C. E. Vreim | Paradis Il | K. McNeil | R. Davis
[1] C. Smith. Patient selection, evaluation, and preoperative management for lung transplant candidates. , 1997, Clinics in chest medicine.
[2] P. Gilligan,et al. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. , 1997, American journal of respiratory and critical care medicine.
[3] G. Patterson,et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.
[4] L Goldman,et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.
[5] R. Casaburi,et al. Lung volume reduction surgery. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, May 1996. , 1996, American journal of respiratory and critical care medicine.
[6] T. Egan,et al. Severe osteoporosis before and after lung transplantation. , 1996, Chest.
[7] B. Groves,et al. Pulmonary hypertension in chronic liver disease. , 1996, Clinics in chest medicine.
[8] P. Macklem,et al. Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[9] B. Groves,et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.
[10] R. Mckenna,et al. A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.
[11] R. Wu,et al. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. , 1995, Chest.
[12] W. Gersony,et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. , 1995, Circulation.
[13] J. Peters,et al. Single lung transplantation in patients with systemic disease. , 1994, Chest.
[14] D. Schwartz,et al. Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.
[15] D. Geddes,et al. Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. , 1993, Paediatric and perinatal epidemiology.
[16] D. Cattran,et al. CYCLOSPORINE NEPHROTOXICITY IN LUNG TRANSPLANT RECIPIENTS , 1992, Transplantation.
[17] M. Corey,et al. Prediction of mortality in patients with cystic fibrosis. , 1992, The New England journal of medicine.
[18] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[19] G. Raghu,et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.
[20] R. Calne,et al. TRANSPLANTATION OF LIVER, HEART, AND LUNGS FOR PRIMARY BILIARY CIRRHOSIS AND PRIMARY PULMONARY HYPERTENSION , 1987, The Lancet.
[21] B. Burrows,et al. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.
[22] B. Griffith,et al. Critical issues in pediatric lung transplantation. , 1995, The Journal of thoracic and cardiovascular surgery.
[23] D. Stover,et al. Lung transplantation for chemotherapy-induced pulmonary fibrosis. , 1994, Chest.